ULY vs MNRO

For growth investors, Monro, Inc.

(MNRO) is the stronger pick with -6. 4% revenue growth year-over-year, versus -22. 6% for Urgent. ly Inc. Common Stock (ULY). Analysts rate Monro, Inc. (MNRO) a "Hold" — based on 24 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, Monro, Inc.

(MNRO) delivered a total return of -67. 6%, compared to -92. 1% for Urgent. ly Inc. Common Stock (ULY). Over 10 years, the gap is even starker: MNRO returned -62. 4% versus ULY's -92. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Monro, Inc.

(MNRO) is the lower-risk stock at 1. 50β versus Urgent. ly Inc. Common Stock's 1. 70β — meaning ULY is approximately 13% more volatile than MNRO relative to the S&P 500.

By revenue growth (latest reported year), Monro, Inc.

(MNRO) is pulling ahead at -6. 4% versus -22. 6% for Urgent. ly Inc. Common Stock (ULY). On earnings-per-share growth, the picture is similar: Monro, Inc. grew EPS -119. 3% year-over-year, compared to -797. 7% for Urgent. ly Inc. Common Stock. Over a 3-year CAGR, ULY leads at -1. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Monro, Inc.

(MNRO) is the more profitable company, earning -0. 4% net margin versus -30. 8% for Urgent. ly Inc. Common Stock — meaning it keeps -0. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MNRO leads at 3. 4% versus -19. 0% for ULY. At the gross margin level — before operating expenses — MNRO leads at 34. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

In this comparison, MNRO (6.

4% yield) pays a dividend. ULY does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Monro, Inc.

(MNRO) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (6. 4% yield). Urgent. ly Inc. Common Stock (ULY) carries a higher beta of 1. 70 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (MNRO: -62. 4%, ULY: -92. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (ULY (Technology) and MNRO (Consumer Cyclical)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: ULY is a small-cap quality compounder stock; MNRO is a small-cap income-oriented stock. MNRO pays a dividend while ULY does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.